DRKS00013028
Recruiting
Not Applicable
Evaluation of metabolic bone disease and fracture prevalence in patients with Crohn’s disease - CROHN-BONE
udwig Boltzmann Institut für Osteologie0 sites218 target enrollmentSeptember 14, 2017
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- K50.9
- Sponsor
- udwig Boltzmann Institut für Osteologie
- Enrollment
- 218
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with Crohn´s disease at least 18 years old
- •Control subjects will be recruited from a preventive medical examination program.
Exclusion Criteria
- •Critically or terminally ill patients.
- •Unable to comply with study protocol.
- •Pregnancy (positive urine pregnancy test)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
Study on Bone Metabolic Mechanism and Clinical Application of Qianggu Yin in the treatment of Primary Type I OsteoporosisPrimary type I osteoporosisITMCTR2000004058The Second Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine
Completed
Not Applicable
Evaluation of Bone Metabolism Biomarkers in Periodontal DiseasesPeriodontal DiseasesNCT05702892Necmettin Erbakan University60
Completed
Not Applicable
Assessment of bone related bio-markers in patients with rheumatoid arthritis treated with Certolizumab pegolrheumatoid arthritisJPRN-UMIN000029594Graduate School of Medicine, Osaka University Department of Respiratory Medicine and Clinical Immunology40
Recruiting
Not Applicable
The evaluations of glucose metabolism, bone metabolism, vascular endothelial function and lipid metabolism by the hormone which regulates circadian rhythm in type 2 diabetes.JPRN-UMIN000019018niversity of Occupational and Environmental Health, Japan, First Department of Internal Medicine, School of Medicine168
Completed
Not Applicable
A study on bone metabolism in patients with long-term use of anti-epileptic drugsepilepsyJPRN-UMIN000008116Division of Neurology, Kobe University Hospital50